We are live on ! Find out more
CAM

ClariVest Asset Management Portfolio holdings

AUM $980M
1-Year Est. Return 60.89%
This Fund
S&P 500
This Quarter Est. Return
+13.68%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$4.36B
AUM Growth
-$93.8M
Cap. Flow
-$560M
Cap. Flow %
-12.85%
Top 10 Hldgs %
30.91%
Holding
760
New
81
Increased
74
Reduced
395
Closed
103

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$24.5M
2
LEN icon
Lennar Class A
LEN
+$21.8M
3
CPRT icon
Copart
CPRT
+$21M
4
LRCX icon
Lam Research
LRCX
+$19.4M
5
TTD icon
Trade Desk
TTD
+$19.1M

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$41.7M
2
MSFT icon
Microsoft
MSFT
+$23.1M
3
ADBE icon
Adobe
ADBE
+$22.6M
4
XLNX
Xilinx Inc
XLNX
+$19.8M
5
UNP icon
Union Pacific
UNP
+$18.7M

Sector Composition

Rank Sector Weight
1 Technology 30.24%
2 Consumer Discretionary 14.05%
3 Healthcare 13.74%
4 Communication Services 10.34%
5 Financials 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDE icon
601
Coeur Mining
CDE
$17.9B
$1K ﹤0.01%
88
CDNS icon
602
Cadence Design Systems
CDNS
$93.4B
$1K ﹤0.01%
21
CHH icon
603
Choice Hotels
CHH
$4.8B
$1K ﹤0.01%
8
CRL icon
604
Charles River Laboratories
CRL
$12.8B
$1K ﹤0.01%
8
-33,037
-100% -$4.57M
CROX icon
605
Crocs
CROX
$6.55B
$1K ﹤0.01%
16
DHR icon
606
Danaher
DHR
$144B
$1K ﹤0.01%
8
-2,073
-100% -$262K
DINO icon
607
HF Sinclair
DINO
$14.5B
$1K ﹤0.01%
15
EW icon
608
Edwards Lifesciences
EW
$51.7B
$1K ﹤0.01%
9
G icon
609
Genpact
G
$5.81B
$1K ﹤0.01%
23
GLOB icon
610
Globant
GLOB
$1.61B
$1K ﹤0.01%
8
-18,700
-100% -$1.86M
HII icon
611
Huntington Ingalls Industries
HII
$12.8B
$1K ﹤0.01%
5
HUM icon
612
Humana
HUM
$46.2B
$1K ﹤0.01%
4
PPLI
613
People Inc
PPLI
$3.1B
$1K ﹤0.01%
22
ICFI icon
614
ICF International
ICFI
$1.72B
$1K ﹤0.01%
8
IDXX icon
615
Idexx Laboratories
IDXX
$46.2B
$1K ﹤0.01%
5
INCY icon
616
Incyte
INCY
$24.4B
$1K ﹤0.01%
8
IOSP icon
617
Innospec
IOSP
$2.28B
$1K ﹤0.01%
5
IQV icon
618
IQVIA
IQV
$39.3B
$1K ﹤0.01%
6
J icon
619
Jacobs Solutions
J
$17B
$1K ﹤0.01%
15
MD icon
620
Pediatrix Medical
MD
$2.2B
$1K ﹤0.01%
+25
New +$627
MO icon
621
Altria Group
MO
$114B
$1K ﹤0.01%
12
MTD icon
622
Mettler-Toledo International
MTD
$28.6B
$1K ﹤0.01%
1
-1
-50% -$722
NCLH icon
623
Norwegian Cruise Line
NCLH
$8.84B
$1K ﹤0.01%
14
OKTA icon
624
Okta
OKTA
$25.8B
$1K ﹤0.01%
9
ON icon
625
ON Semiconductor
ON
$19.3B
$1K ﹤0.01%
35

Similar funds

ClariVest Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, ClariVest Asset Management held 760 positions worth $4.36B, down 2.1% from $4.45B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

ClariVest Asset Management withdrew a net $560M in Q4 2019, closing 103 positions and reducing 395 holdings. Its most notable exit was Progressive, an estimated $41.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, ClariVest Asset Management opened a new position in Bristol-Myers Squibb worth $27.5M.

  • ClariVest Asset Management's largest Q4 2019 buy was Bristol-Myers Squibb: 428,479 shares worth $27.5M.
  • ClariVest Asset Management added most to Copart in Q4 2019, an estimated $21M increase.
  • ClariVest Asset Management's biggest Q4 2019 reduction was Microsoft, cutting an estimated $23.1M.
  • ClariVest Asset Management fully exited Progressive in Q4 2019, selling an estimated $41.7M.
  • ClariVest Asset Management's ten largest holdings make up 31% of its $4.36B portfolio in Q4 2019.
  • ClariVest Asset Management opened 81 new positions and closed 103 in Q4 2019.
  • ClariVest Asset Management's portfolio value fell 2.1% quarter-over-quarter to $4.36B.

Based on ClariVest Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.